Cargando…

Moderate Vaccine Effectiveness against Severe Acute Respiratory Infection Caused by A(H1N1)pdm09 Influenza Virus and No Effectiveness against A(H3N2) Influenza Virus in the 2018/2019 Season in Italy

Every season, circulating influenza viruses change; therefore, vaccines must be reformulated each year. We aimed to estimate vaccine effectiveness (VE) against severe influenza infection for the 2018/19 season in Italy. We conducted a test-negative design case-control study at five Italian hospitals...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rizzo, Caterina, Gesualdo, Francesco, Loconsole, Daniela, Pandolfi, Elisabetta, Bella, Antonino, Orsi, Andrea, Guarona, Giulia, Panatto, Donatella, Icardi, Giancarlo, Napoli, Christian, Orsi, Giovanni Battista, Manini, Ilaria, Montomoli, Emanuele, Campagna, Ilaria, Russo, Luisa, Alfonsi, Valeria, Puzelli, Simona, Reale, Antonino, Raucci, Umberto, Piccioni, Livia, Concato, Carlo, Ciofi Degli Atti, Marta Luisa, Villani, Alberto, Chironna, Maria, Tozzi, Alberto Eugenio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564262/ https://www.ncbi.nlm.nih.gov/pubmed/32751584 http://dx.doi.org/10.3390/vaccines8030427

Ejemplares similares

Surveillance of Severe Acute Respiratory Infection and Influenza Vaccine Effectiveness among Hospitalized Italian Adults, 2021/22 Season
por: Panatto, Donatella, et al.
Publicado: (2022)

COVID-19 and Seasonal Influenza Vaccination: Cross-Protection, Co-Administration, Combination Vaccines, and Hesitancy
por: Domnich, Alexander, et al.
Publicado: (2022)

No evidence of SARS-CoV-2 in hospitalized patients with severe acute respiratory syndrome in five Italian hospitals from 1(st) November 2019 to 29(th) February 2020
por: Panatto, Donatella, et al.
Publicado: (2021)

Pandemic Influenza A/H1N1pdm in Italy: Age, Risk and Population Susceptibility
por: Merler, Stefano, et al.
Publicado: (2013)

Enhanced passive safety surveillance of the MF59-adjuvanted quadrivalent influenza vaccine in the elderly during the 2021/22 influenza season
por: Amicizia, Daniela, et al.
Publicado: (2023)

Detection of influenza A(H1N1)pdm09 virus in a patient travelling from Shanghai to Italy in July 2018: an uncommon clinical presentation in a non-seasonal period
por: BUTERA, F., et al.
Publicado: (2019)

Three seasons of enhanced safety surveillance of a cell culture-based quadrivalent influenza vaccine
por: Domnich, Alexander, et al.
Publicado: (2023)

Population-level benefits of increasing influenza vaccination uptake among Italian older adults: results from a granular panel model
por: Domnich, Alexander, et al.
Publicado: (2023)

Development of Live-Attenuated Influenza Vaccines against Outbreaks of H5N1 Influenza
por: Zheng, Dan, et al.
Publicado: (2012)

Preclinical and Clinical Development of Plant-Made Virus-Like Particle Vaccine against Avian H5N1 Influenza
por: Landry, Nathalie, et al.
Publicado: (2010)

Immunogenicity Measures of Influenza Vaccines: A Study of 1164 Registered Clinical Trials
por: Domnich, Alexander, et al.
Publicado: (2020)

Influenza A(H7N7) Virus among Poultry Workers, Italy, 2013
por: Puzelli, Simona, et al.
Publicado: (2016)

Protection against Divergent Influenza H1N1 Virus by a Centralized Influenza Hemagglutinin
por: Weaver, Eric A., et al.
Publicado: (2011)

A replication-deficient H9N2 influenza virus carrying H5 hemagglutinin conferred protection against H9N2 and H5N1 influenza viruses in mice
por: Ren, Weigang, et al.
Publicado: (2022)

Trends for Influenza-related Deaths during Pandemic and Epidemic Seasons, Italy, 1969–2001
por: Rizzo, Caterina, et al.
Publicado: (2007)

Current evidence on intradermal influenza vaccines administered by Soluvia™ licensed micro injection system
por: Icardi, Giancarlo, et al.
Publicado: (2012)

Vaccination against Human Influenza A/H3N2 Virus Prevents the Induction of Heterosubtypic Immunity against Lethal Infection with Avian Influenza A/H5N1 Virus
por: Bodewes, Rogier, et al.
Publicado: (2009)

Understanding the dynamics of seasonal influenza in Italy: incidence, transmissibility and population susceptibility in a 9‐year period
por: Lunelli, Antonella, et al.
Publicado: (2012)

Sars-Cov2 Not Detected in a Pediatric Population With Acute Respiratory Infection in Primary Care in Central and Southern Italy From November 2019 to Early March 2020
por: Rizzo, Caterina, et al.
Publicado: (2021)

Increasing Influenza Vaccination Uptake by Sending Reminders: A Representative Cross-Sectional Study on the Preferences of Italian Adults
por: Domnich, Alexander, et al.
Publicado: (2023)

Efficacy of Live-Attenuated H9N2 Influenza Vaccine Candidates Containing NS1 Truncations against H9N2 Avian Influenza Viruses
por: Chen, Sujuan, et al.
Publicado: (2017)

Prophylactic and Therapeutic Efficacy of Avian Antibodies Against Influenza Virus H5N1 and H1N1 in Mice
por: Nguyen, Huan H., et al.
Publicado: (2010)

Microneutralization Assay Titres Correlate with Protection against Seasonal Influenza H1N1 and H3N2 in Children
por: Verschoor, Chris P., et al.
Publicado: (2015)

Immune-engineered H7N9 influenza hemagglutinin improves protection against viral influenza virus challenge
por: Jang, Hyesun, et al.
Publicado: (2020)

An exploratory study to assess patterns of influenza- and pneumonia-related mortality among the Italian elderly
por: Fallani, Elettra, et al.
Publicado: (2021)

Acceptance of COVID-19 and Influenza Vaccine Co-Administration: Insights from a Representative Italian Survey
por: Domnich, Alexander, et al.
Publicado: (2022)

Single Dose of Bivalent H5 and H7 Influenza Virus-Like Particle Protects Chickens Against Highly Pathogenic H5N1 and H7N9 Avian Influenza Viruses
por: Hu, Jiao, et al.
Publicado: (2021)

Assessment of 2021/22 influenza epidemic scenarios in Italy during SARS-CoV-2 outbreak
por: Chironna, Maria, et al.
Publicado: (2023)

Serologically-Based Evaluation of Cross-Protection Antibody Responses among Different A(H1N1) Influenza Strains
por: Marchi, Serena, et al.
Publicado: (2020)

Effectiveness of influenza vaccine against influenza A in Europe in seasons of different A(H1N1)pdm09 and the same A(H3N2) vaccine components (2016–17 and 2017–18)
por: Kissling, Esther, et al.
Publicado: (2019)

Determining Risk Factors for Infection with Influenza A (H5N1)
por: Lukrafka, Janice Luisa, et al.
Publicado: (2007)

Changes in Attitudes and Beliefs Concerning Vaccination and Influenza Vaccines between the First and Second COVID-19 Pandemic Waves: A Longitudinal Study
por: Domnich, Alexander, et al.
Publicado: (2021)

Invasive Type e Haemophilus influenzae Disease in Italy
por: Cerquetti, Marina, et al.
Publicado: (2003)

Human Infection with Highly Pathogenic A(H7N7) Avian Influenza Virus, Italy, 2013
por: Puzelli, Simona, et al.
Publicado: (2014)

Correction: Microneutralization Assay Titres Correlate with Protection against Seasonal Influenza H1N1 and H3N2 in Children
por: Verschoor, Chris P., et al.
Publicado: (2016)

Split inactivated COBRA vaccine elicits protective antibodies against H1N1 and H3N2 influenza viruses
por: Allen, James D., et al.
Publicado: (2018)

Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses
por: Bahl, Kapil, et al.
Publicado: (2017)

Systemic and respiratory T-cells induced by seasonal H1N1 influenza protect against pandemic H2N2 in ferrets
por: van de Ven, Koen, et al.
Publicado: (2020)

Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses
por: Bahl, Kapil, et al.
Publicado: (2022)

Detection of antibodies against influenza D virus in swine veterinarians in Italy in 2004
por: Trombetta, Claudia Maria, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_msaj99bkdmmvfsvngjie1nrc6q